| An overview of severe acute respiratory syndrome–coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy T Pillaiyar, M Manickam, V Namasivayam, Y Hayashi, SH Jung Journal of medicinal chemistry 59 (14), 6595-6628, 2016 | 796 | 2016 |
| Inhibitors of melanogenesis: an updated review T Pillaiyar, V Namasivayam, M Manickam, SH Jung Journal of medicinal chemistry 61 (17), 7395-7418, 2018 | 277 | 2018 |
| Inhibitory action of novel aromatic diamine compound on lipopolysaccharide‐induced nuclear translocation of NF‐κB without affecting IκB degradation HM Shin, MH Kim, BH Kim, SH Jung, YS Kim, HJ Park, JT Hong, KR Min, ... FEBS letters 571 (1-3), 50-54, 2004 | 277 | 2004 |
| Recent development of signaling pathways inhibitors of melanogenesis T Pillaiyar, M Manickam, SH Jung Cellular signalling 40, 99-115, 2017 | 226 | 2017 |
| Downregulation of melanogenesis: drug discovery and therapeutic options T Pillaiyar, M Manickam, SH Jung Drug Discovery Today 22 (2), 282-298, 2017 | 147 | 2017 |
| Design and synthesis of novel 2-(indol-5-yl) thiazole derivatives as xanthine oxidase inhibitors JU Song, SP Choi, TH Kim, CK Jung, JY Lee, SH Jung, GT Kim Bioorganic & medicinal chemistry letters 25 (6), 1254-1258, 2015 | 90 | 2015 |
| Structural requirement of chalcones for the inhibitory activity of interleukin-5 HM Yang, HR Shin, SH Cho, SC Bang, GY Song, JH Ju, MK Kim, SH Lee, ... Bioorganic & Medicinal Chemistry 15 (1), 104-111, 2007 | 88 | 2007 |
| Structural requirement (s) of N-phenylthioureas and benzaldehyde thiosemicarbazones as inhibitors of melanogenesis in melanoma B 16 cells P Thanigaimalai, TA Le Hoang, KC Lee, SC Bang, VK Sharma, CY Yun, ... Bioorganic & medicinal chemistry letters 20 (9), 2991-2993, 2010 | 78 | 2010 |
| Inhibitors of melanogenesis: a patent review (2009–2014) T Pillaiyar, M Manickam, SH Jung Expert opinion on therapeutic patents 25 (7), 775-788, 2015 | 73 | 2015 |
| MD-2 as the target of nonlipid chalcone in the inhibition of endotoxin LPS-induced TLR4 activity E Roh, HS Lee, JA Kwak, JT Hong, SY Nam, SH Jung, JY Lee, ND Kim, ... The Journal of infectious diseases 203 (7), 1012-1020, 2011 | 69 | 2011 |
| A novel stereo-selective sulfonylurea, 1-[1-(4-aminobenzoyl)-2, 3-dihydro-1H-indol-6-sulfonyl]-4-phenyl-imidazolidin-2-one, has antitumor efficacy in in vitro and in vivo tumor … CW Lee, DH Hong, SB Han, SH Jung, HC Kim, RL Fine, SH Lee, HM Kim Biochemical pharmacology 64 (3), 473-480, 2002 | 68 | 2002 |
| Structural requirement of isoflavonones for the inhibitory activity of interleukin-5 SH Jung, SH Cho, TH Dang, JH Lee, JH Ju, MK Kim, SH Lee, JC Ryu, ... European journal of medicinal chemistry 38 (5), 537-545, 2003 | 66 | 2003 |
| Anti-inflammatory mode of isoflavone glycoside sophoricoside by inhibition of lnterleukin-6 and cyclooxygenase-2 in inflammatory response BH Kim, EY Chung, JC Ryu, SH Jung, KR Min, Y Kim Archives of pharmacal research 26, 306-311, 2003 | 63 | 2003 |
| Benzoxathiole derivative blocks lipopolysaccharide-induced nuclear factor-κB activation and nuclear factor-κB-regulated gene transcription through inactivating inhibitory κB … BH Kim, E Roh, HY Lee, IJ Lee, B Ahn, SH Jung, H Lee, SB Han, Y Kim Molecular Pharmacology 73 (4), 1309-1318, 2008 | 61 | 2008 |
| Structure-based design and biological evaluation of novel 2-(indol-2-yl) thiazole derivatives as xanthine oxidase inhibitors JU Song, JW Jang, TH Kim, H Park, WS Park, SH Jung, GT Kim Bioorganic & medicinal chemistry letters 26 (3), 950-954, 2016 | 59 | 2016 |
| Terpenoids and coumarins isolated from the fruits of Poncirus trifoliata GH Xu, JA Kim, SY Kim, JC Ryu, YS Kim, SH Jung, MK Kim, SH Lee Chemical and Pharmaceutical Bulletin 56 (6), 839-842, 2008 | 51 | 2008 |
| IRAK4 as a molecular target in the amelioration of innate immunity–related endotoxic shock and acute liver injury by chlorogenic acid SH Park, SI Baek, J Yun, S Lee, DY Yoon, JK Jung, SH Jung, BY Hwang, ... The Journal of Immunology 194 (3), 1122-1130, 2015 | 49 | 2015 |
| Characterization of the anticancer activity of DW2282, a new anticancer agent. HS Hwang, EY Moon, SK Seong, CH Choi, YH Chung, SH Jung, DK Lee, ... Anticancer research 19 (6B), 5087-5093, 1999 | 44 | 1999 |
| Evaluation of 3, 4-dihydroquinazoline-2 (1H)-thiones as inhibitors of α-MSH-induced melanin production in melanoma B16 cells P Thanigaimalai, KC Lee, SC Bang, JH Lee, CY Yun, E Roh, BY Hwang, ... Bioorganic & medicinal chemistry 18 (4), 1555-1562, 2010 | 42 | 2010 |
| Structural characteristics of thiosemicarbazones as inhibitors of melanogenesis KC Lee, P Thanigaimalai, VK Sharma, MS Kim, E Roh, BY Hwang, Y Kim, ... Bioorganic & medicinal chemistry letters 20 (22), 6794-6796, 2010 | 41 | 2010 |
